In the future, techniques to improve liver cell engraftment (see above) or liver Pex1 gene therapy could be evaluated in this mild ZSD mouse model to restore liver peroxisome biogenesis. This evidence concerns the gene PEX1 and peroxisome biogenesis disorder.